Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 31;16(11):2106.
doi: 10.3390/cancers16112106.

Qualitative Classification of Late Systemic Symptoms in Head and Neck Cancer Survivors

Affiliations

Qualitative Classification of Late Systemic Symptoms in Head and Neck Cancer Survivors

Poppy Schoenberg et al. Cancers (Basel). .

Abstract

Improved rates of cancer control have increased the head and neck cancer survivor population. Cancer survivorship clinics are not widely available in the USA, and longitudinal supportive care for patients undergoing multimodal therapy has not advanced at a pace commensurate with improvements in cancer control. Consequently, a large head and neck cancer survivor population whose quality of life may be chronically and/or permanently diminished presently exists. This lack of awareness perpetuates under-recognition and under-investigation, leaving survivors' (mostly detrimental) experiences largely uncharted. We conducted a qualitative exploration of survivors' experiences, aiming to unpack the profound impact of late systemic symptoms on daily life, encompassing work, relationships, and self-identity in the head and neck cancer survivor community. The study included 15 remitted head and neck survivors, ≥12 months from their final treatment, who participated in semi-structured interviews conducted by a medical oncologist. Data analysis comprised qualitative thematic analysis, specifically inductive hierarchical linear modeling, enriched by a deductive approach of anecdotal clinical reporting. Results highlighted that 43.36% of all quotation material discussed in the interviews pertained to chronic emotion disturbance with significant implications for other domains of life. A central symptom cluster comprised impairments in mood/emotions, daily activity, and significant fatigue. Dysfunction in sleep, other medical conditions, and cognitive deficits comprised a secondary cluster. Physical dysfunctionality, encompassing pain, appetite, and eating, and alterations in experienced body temperature, constituted a tertiary cluster, and perhaps were surprisingly the least discussed symptom burden among head and neck cancer survivors. Symptoms causing heightened long-term survivor burden may be considered epiphenomenal to central physical dysfunctionality, albeit being presently the least represented in cancer survivor care programs. Moving forward, the development of targeted and multi-dimensional treatment programs that encompass physical, psychosocial, and spiritual domains are needed to increase clinical specificity and effective holistic long-term solutions that will foster a more compassionate and informed future of care for the cancer survivorship community.

Keywords: cancer survivorship; emotional disturbance; fatigue; head and neck cancer; pain; social support; spirituality; systemic symptoms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest, except Dr. Wulff-Burchfield, who would like to mention that she is a consultant/advisor for Astellas, Aveo Oncology, BMS, Exelixis, Janssen, and Pfizer, and has stock ownership in Nektar.

Figures

Figure 1
Figure 1
Classification framework of bio–psycho–social dimensions associated with the cancer trajectory and cancer survivorship. * ADL = activities of daily living.

Similar articles

References

    1. Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer Statistics, 2024. CA Cancer J. Clin. 2024;74:12–49. doi: 10.3322/caac.21820. - DOI - PubMed
    1. Forastiere A.A., Trotti A., Pfister D.G., Grandis J.R. Head and neck cancer: Recent advances and new standards of care. J. Clin. Oncol. 2006;24:2603–2605. doi: 10.1200/JCO.2006.07.1464. - DOI - PubMed
    1. Howlader N., Noone A.M., Krapcho M., Miller D., Brest A., Yu M., Ruhl J., Tatalovich Z., Mariotto A., Lewis D.R., et al., editors. SEER Cancer Statistics Review, 1975–2018. National Cancer Institute; Bethesda, MD, USA: 2021.
    1. Bell K., Ristovski-Slijepcevic S. Cancer Survivorship: Why Labels Matter. J. Clin. Oncol. 2013;31:409–411. doi: 10.1200/JCO.2012.43.5891. - DOI - PubMed
    1. Yamazaki T., Enokida T., Wakasugi T., Zenda S., Motegi A., Arahira S., Akimoto T., Tahara M. Impact of prophylactic percutaneous endoscopic gastrostomy tube placement on treatment tolerance in head and neck cancer patients treated with cetuximab plus radiation. Jpn. J. Clin. Oncol. 2016;46:825–831. doi: 10.1093/jjco/hyw079. - DOI - PubMed

LinkOut - more resources